Fresenius Medical Care AG & Co., the world’s largest provider of dialysis equipment and related services, has agreed to pay U.S. authorities nearly $232 million to resolve allegations that it bribed doctors and health officials in some 17 countries in order to obtain business.

The German company also agreed to hire an independent compliance monitor for two years, remove 10 employees involved in the schemes, enhance its compliance program, adopt heightened controls on selecting third-party agents and withdraw from pending public contracts potentially related to the misconduct, according to the nonprosecution agreement the company signed with the U.S. Department of Justice.